Literature DB >> 1740376

Visual evoked potentials after photostress in patients with primary open-angle glaucoma and ocular hypertension.

V Parisi1, M G Bucci.   

Abstract

Visual evoked potentials (VEPs) were assessed in basal condition and after photostress in normal subjects, in subjects with ocular hypertension (OHT), and in subjects with primary open-angle glaucoma (POAG). The VEPs recorded in basal condition showed that in patients with OHT and POAG a latency of the P100 peak was higher than in controls. The amplitudes were reduced in POAG patients but not in OHT patients. In all eyes, the VEPs recorded 20 s after photostress showed an increase in latency and a decrease in amplitude. In the control eyes, the functional recovery was complete after 80 s. In the eyes with OHP and in the eyes with POAG, the parameters of VEP after photostress underwent greater changes than in the control eyes. VEPs were superimposable on the basal condition (recovery time) at 73.2 s in OHT patients and at 113.2 s in POAG patients. The longer VEP recovery time after photostress observed in OHT and POAG patients could be attributed to the reduced functionality of the outer layers or the inner retinal layers of the central retina, or both. This test may be useful in the clinical evaluation for early diagnosis of glaucoma.

Entities:  

Mesh:

Year:  1992        PMID: 1740376

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  Electrophysiological evaluation of the macular cone adaptation: VEP after photostress. A review.

Authors:  V Parisi
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

2.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

3.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

4.  Extrafoveal photostress recovery test in glaucoma and idiopathic central serous chorioretinopathy.

Authors:  M Horiguchi; Y Ito; Y Miyake
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

5.  Neural conduction in the visual pathways in ocular hypertension and glaucoma.

Authors:  V Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

6.  [Flicker provocation with LED full-field stimulation in normals and glaucoma patients].

Authors:  F K Horn; B Link; K Dehne; R Lämmer; A G Jünemann
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

7.  Visual evoked potentials after photostress in newly diagnosed insulin-dependent diabetes patients.

Authors:  V Parisi; L Uccioli; G Monticone; L Parisi; L Durola; C Pernini; R Neuschuler; G Menzinger; M G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

8.  [Recovery time as a potential new progression parameter for patients with advanced glaucomatous optic atrophy].

Authors:  B Hohberger; S Mißlinger; F Horn; J Kremers
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

9.  Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy.

Authors:  V Parisi; L Uccioli; G Monticone; L Parisi; G Menzinger; M G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

10.  Electrophysiological assessment of visual function in newly-diagnosed IDDM patients.

Authors:  L Uccioli; V Parisi; G Monticone; L Parisi; L Durola; C Pernini; R Neuschuler; M G Bucci; G Menzinger
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.